These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28368411)

  • 1. PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4.
    Ueno N; Nishimura N; Ueno S; Endo S; Tatetsu H; Hirata S; Hata H; Matsuoka M; Mitsuya H; Okuno Y
    Oncogene; 2017 Aug; 36(31):4481-4497. PubMed ID: 28368411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PU.1 induces apoptosis in myeloma cells through direct transactivation of TRAIL.
    Ueno S; Tatetsu H; Hata H; Iino T; Niiro H; Akashi K; Tenen DG; Mitsuya H; Okuno Y
    Oncogene; 2009 Nov; 28(46):4116-25. PubMed ID: 19749795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of PU.1 by methylation of distal regulatory elements and the promoter is required for myeloma cell growth.
    Tatetsu H; Ueno S; Hata H; Yamada Y; Takeya M; Mitsuya H; Tenen DG; Okuno Y
    Cancer Res; 2007 Jun; 67(11):5328-36. PubMed ID: 17545613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages.
    Marecki S; Atchison ML; Fenton MJ
    J Immunol; 1999 Sep; 163(5):2713-22. PubMed ID: 10453013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Transcription Factors PU.1 and IRF4 Determine Dendritic Cell-Specific Expression of RALDH2.
    Yashiro T; Yamaguchi M; Watanuki Y; Kasakura K; Nishiyama C
    J Immunol; 2018 Dec; 201(12):3677-3682. PubMed ID: 30413670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoring PU.1 induces apoptosis and modulates viral transactivation via interferon-stimulated genes in primary effusion lymphoma.
    Goto H; Kariya R; Kudo E; Okuno Y; Ueda K; Katano H; Okada S
    Oncogene; 2017 Sep; 36(37):5252-5262. PubMed ID: 28481873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PU.1 cooperates with IRF4 and IRF8 to suppress pre-B-cell leukemia.
    Pang SH; Minnich M; Gangatirkar P; Zheng Z; Ebert A; Song G; Dickins RA; Corcoran LM; Mullighan CG; Busslinger M; Huntington ND; Nutt SL; Carotta S
    Leukemia; 2016 Jun; 30(6):1375-87. PubMed ID: 26932576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A xenograft model reveals that PU.1 functions as a tumor suppressor for multiple myeloma in vivo.
    Nishimura N; Endo S; Ueno S; Ueno N; Tatetsu H; Hirata S; Hata H; Komohara Y; Takeya M; Mitsuya H; Okuno Y
    Biochem Biophys Res Commun; 2017 May; 486(4):916-922. PubMed ID: 28347818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple myeloma oncogene 1 (MUM1)/interferon regulatory factor 4 (IRF4) upregulates monokine induced by interferon-gamma (MIG) gene expression in B-cell malignancy.
    Uranishi M; Iida S; Sanda T; Ishida T; Tajima E; Ito M; Komatsu H; Inagaki H; Ueda R
    Leukemia; 2005 Aug; 19(8):1471-8. PubMed ID: 15959530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hematopoietic cell-specific transcription factor PU.1 is critical for expression of CD11c.
    Yashiro T; Kasakura K; Oda Y; Kitamura N; Inoue A; Nakamura S; Yokoyama H; Fukuyama K; Hara M; Ogawa H; Okumura K; Nishiyama M; Nishiyama C
    Int Immunol; 2017 Feb; 29(2):87-94. PubMed ID: 28338898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factors PU.1 and IRF4 regulate activation induced cytidine deaminase in chicken B cells.
    Luo H; Tian M
    Mol Immunol; 2010 Apr; 47(7-8):1383-95. PubMed ID: 20299102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PU.1, interferon regulatory factor (IRF) 2, and the interferon consensus sequence-binding protein (ICSBP/IRF8) cooperate to activate NF1 transcription in differentiating myeloid cells.
    Huang W; Horvath E; Eklund EA
    J Biol Chem; 2007 Mar; 282(9):6629-43. PubMed ID: 17200120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo.
    Morelli E; Leone E; Cantafio ME; Di Martino MT; Amodio N; Biamonte L; Gullà A; Foresta U; Pitari MR; Botta C; Rossi M; Neri A; Munshi NC; Anderson KC; Tagliaferri P; Tassone P
    Leukemia; 2015 Nov; 29(11):2173-83. PubMed ID: 25987254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PU.1 regulates positive regulatory domain I-binding factor 1/Blimp-1 transcription in lymphoma cells.
    Desai S; Bolick SC; Maurin M; Wright KL
    J Immunol; 2009 Nov; 183(9):5778-87. PubMed ID: 19828640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines.
    Ahyi AN; Chang HC; Dent AL; Nutt SL; Kaplan MH
    J Immunol; 2009 Aug; 183(3):1598-606. PubMed ID: 19592658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PU.1 is a potent tumor suppressor in classical Hodgkin lymphoma cells.
    Yuki H; Ueno S; Tatetsu H; Niiro H; Iino T; Endo S; Kawano Y; Komohara Y; Takeya M; Hata H; Okada S; Watanabe T; Akashi K; Mitsuya H; Okuno Y
    Blood; 2013 Feb; 121(6):962-70. PubMed ID: 23212521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMSET regulates expression of IRF4 in t(4;14) myeloma and its silencing potentiates the effect of bortezomib.
    Xie Z; Bi C; Chooi JY; Chan ZL; Mustafa N; Chng WJ
    Leukemia; 2015 Dec; 29(12):2347-54. PubMed ID: 26196464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRF4 addiction in multiple myeloma.
    Shaffer AL; Emre NC; Lamy L; Ngo VN; Wright G; Xiao W; Powell J; Dave S; Yu X; Zhao H; Zeng Y; Chen B; Epstein J; Staudt LM
    Nature; 2008 Jul; 454(7201):226-31. PubMed ID: 18568025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Roles of PU.1 in the Expression of PD-L2: Direct Transactivation with IRF4 and Indirect Epigenetic Regulation.
    Inaba K; Yashiro T; Hiroki I; Watanabe R; Kasakura K; Nishiyama C
    J Immunol; 2020 Aug; 205(3):822-829. PubMed ID: 32611724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory drugs act as inhibitors of DNA methyltransferases and induce PU.1 up-regulation in myeloma cells.
    Endo S; Amano M; Nishimura N; Ueno N; Ueno S; Yuki H; Fujiwara S; Wada N; Hirata S; Hata H; Mitsuya H; Okuno Y
    Biochem Biophys Res Commun; 2016 Jan; 469(2):236-42. PubMed ID: 26657848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.